发明名称 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR TREATING HYPERTENSION
摘要 FIELD: chemistry. ^ SUBSTANCE: present invention relates to novel 3,4-substituted pyrrolidine derivatives of general formula or pharmaceutically acceptable salts thereof, where R1 is an acyl selected from values given paragraph 1 of the formula of invention; R2 is unsubstituted C1-C4-alkyl or C3-C7-cycloalkyl; R3 is a fragment selected from a group of fragments of formulae: (a), (b), ^ (c) and (f), where any of the fragments of formulae given above (a), (b) and (f), the star (*) indicates a bond of the corresponding fragment R3 with the molecule residue in formula I; Ra denotes N-C1-C4-alkylaminocarbonyl, N-phenylaminocarbonyl, N-(phenyl-C1-C4-alkyl)aminocarbonyl, N-(C1-C4-alkyl)-N-(phenyl-C1-C4-alkyl)aminocarbonyl, N-(C3-C7-cycloalkyl- C1-C4-alkyl)-N-(phenyl-C1-C4-alkyl)aminocarbonyl, N-(C1-C4-alkyl)-N-(C3-C7-cycloalkyl-C1-C4-alkyl)aminocarbonyl, N,N-di-(C1-C4-alkyl)aminocarbonyl, N-(C3-C7-cycloalkyl)-N-(phenyl-C1-C4-alkyl)aminocarbonyl, N-(C3-C7-cycloalkyl)-N-(tetrahydropyranyl-C1-C4-alkyl)aminocarbonyl, N-(C3-C7-cycloalkyl)-N-(tetrahydropyranyl)aminocarbonyl or hydrogen; Rb and Rc are independently selected from a group comprising unsubstituted C1-C4-alkyl, unsubstituted monocyclic aryl, unsubstituted monocyclic heterocyclyl, unsubstituted or substituted monocyclic C3-C7-cycloalkyl, unsubstituted aryl- C1-C4-alkyl, usubstituted monocyclic C3-C7-cycloalkyl- C1-C4-alkyl, hydrogen or acyl, where the acyl is selected from values given in paragraph 1 of the formula of invention; or Rb and Rc together may form a 6-member nitrogen-containing ring which may be unsubstituted or disubstituted with =O; Rd in the fragment of formula (c) denotes a phenyl or phenyl-C1-C4-alkyl; Re denotes hydrogen or C1-C4-alkyl; and m equals 2; each of R4 and R5 denotes hydrogen; and T denotes methylene. The invention also relates to the pharmaceutical composition based on the compound of formula I and a method of treating hypertension using the compound of formula I. ^ EFFECT: novel pyrrolidine derivatives having renin inhibiting activity are obtained. ^ 7 cl, 19 tbl, 37 ex
申请公布号 RU2419606(C2) 申请公布日期 2011.05.27
申请号 RU20070138892 申请日期 2006.03.21
申请人 NOVARTIS AG 发明人 EHRKHARDT KLAUS;IRIE OSAMU;LORTIUA EHDVIGA LIL'ANA ZHANNA;MAJBAUM JURGEN KLAUS;OSTERMANN NIL'S;ZELL'NER KHOL'GER
分类号 A61K31/341;A61K31/351;A61K31/352;A61K31/357;A61K31/4025;A61K31/4035;A61K31/404;A61K31/416;A61K31/422;A61K31/423;A61K31/4409;A61K31/454;A61K31/4704;A61K31/506;A61K31/5355;A61K31/5377;A61P9/12;C07D207/09;C07D207/16;C07D207/26;C07D207/27;C07D401/12;C07D403/12;C07D405/12;C07D407/12;C07D413/12 主分类号 A61K31/341
代理机构 代理人
主权项
地址